Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
Prime-time Lifetime Achievement Award
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer. Future Oncol. 2010 Jul; 6(7):1073-84.
View in:
PubMed
subject areas
Antiemetics
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Humans
Isoquinolines
Nausea
Neoplasms
Quinuclidines
Risk Factors
Safety
Serotonin Receptor Agonists
Vomiting
authors with profiles
Rudolph Navari